Canada
· Delayed Price · Currency is CAD Bright Minds Biosciences Statistics
Total Valuation
Bright Minds Biosciences has a market cap or net worth of CAD 361.26 million. The enterprise value is 355.66 million.
| Market Cap | 361.26M |
| Enterprise Value | 355.66M |
Important Dates
The last earnings date was Friday, December 27, 2024.
| Earnings Date | Dec 27, 2024 |
| Ex-Dividend Date | n/a |
Share Statistics
Bright Minds Biosciences has 6.99 million shares outstanding. The number of shares has increased by 15.87% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 6.99M |
| Shares Change (YoY) | +15.87% |
| Shares Change (QoQ) | -3.75% |
| Owned by Insiders (%) | 24.45% |
| Owned by Institutions (%) | 4.17% |
| Float | 2.50M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | n/a |
| PB Ratio | 42.24 |
| P/TBV Ratio | 65.25 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | -126.93 |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.32, with a Debt / Equity ratio of 0.02.
| Current Ratio | 11.32 |
| Quick Ratio | 10.91 |
| Debt / Equity | 0.02 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -292.52 |
Financial Efficiency
Return on equity (ROE) is -46.18% and return on invested capital (ROIC) is -26.53%.
| Return on Equity (ROE) | -46.18% |
| Return on Assets (ROA) | -25.19% |
| Return on Capital (ROIC) | -26.53% |
| Revenue Per Employee | n/a |
| Profits Per Employee | n/a |
| Employee Count | n/a |
| Asset Turnover | n/a |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +1,911.52% in the last 52 weeks. The beta is 0.90, so Bright Minds Biosciences's price volatility has been lower than the market average.
| Beta (5Y) | 0.90 |
| 52-Week Price Change | +1,911.52% |
| 50-Day Moving Average | 56.22 |
| 200-Day Moving Average | 20.55 |
| Relative Strength Index (RSI) | 46.63 |
| Average Volume (20 Days) | 1,624 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
| Revenue | n/a |
| Gross Profit | n/a |
| Operating Income | -2.62M |
| Pretax Income | -2.80M |
| Net Income | -2.80M |
| EBITDA | n/a |
| EBIT | -2.62M |
| Earnings Per Share (EPS) | -0.65 |
Balance Sheet
The company has 5.72 million in cash and 118,960 in debt, giving a net cash position of 5.60 million or 0.80 per share.
| Cash & Cash Equivalents | 5.72M |
| Total Debt | 118,960 |
| Net Cash | 5.60M |
| Net Cash Per Share | 0.80 |
| Equity (Book Value) | 5.54M |
| Book Value Per Share | 1.22 |
| Working Capital | 5.46M |
Cash Flow
| Operating Cash Flow | -1.85M |
| Capital Expenditures | n/a |
| Free Cash Flow | n/a |
| FCF Per Share | n/a |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
Bright Minds Biosciences does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -15.87% |
| Shareholder Yield | -15.87% |
| Earnings Yield | -1.26% |
| FCF Yield | n/a |
Stock Splits
The last stock split was on July 14, 2023. It was a reverse split with a ratio of 0.2.
| Last Split Date | Jul 14, 2023 |
| Split Type | Reverse |
| Split Ratio | 0.2 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | n/a |